Even in the group of patients with platinum-based chemotherapy (n = 1409), TIE-1 high expression was also significantly correlated with poor prognosis (Supplementary Fig. S1), suggesting a possible involvement of TIE-1 up-regulation in the acquisition of platinum resistance in ovarian cancer cells. Here, TIE1 is linked to ovarian carcinoma.